MPS Pharmaa quarterly results and financials

MPS Pharmaa (BSE 531686)₹2.080.00%(26 Oct 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), MPS Pharmaa reported sales of ₹0 Cr and net profit of −₹0.35 Cr. For the year to Mar 2026, sales were ₹0 Cr and net profit −₹1.01 Cr.

Sales (Mar 2026): ₹0 Cr
Net profit (Mar 2026): −₹0.35 Cr
Sales (FY Mar 2026): ₹0 Cr
Net profit (FY Mar 2026): −₹1.01 Cr
EPS (Mar 2026): ₹−0.20
Borrowings (Mar 2026): ₹7.52 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

MPS Pharmaa quarterly results

₹ crore unless stated; each column is a quarter.

MPS Pharmaa Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Expenses	0.18	0.20	0.17	0.20	0.18	0.18	0.17	0.18	0.18	0.18	0.18	0.36
Operating Profit	−0.20	−0.22	−0.19	−0.22	−0.20	−0.20	−0.19	−0.20	−0.20	−0.20	−0.20	−0.38
Other Income	0.04	0.07	0.00	0.00	0.00	0.00	0.03	0.00	0.00	0.00	0.00	0.05
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Profit before tax	−0.19	−0.20	−0.23	−0.24	−0.24	−0.24	−0.19	−0.22	−0.24	−0.24	−0.24	−0.36
Tax %	−5.0%	−5.2%	−4.5%	0.0%	−4.3%	−4.3%	0.0%	21.8%	−4.3%	−4.3%	−4.3%	−2.7%
Net Profit	−0.18	−0.17	−0.20	−0.23	−0.21	−0.21	−0.16	−0.27	−0.21	−0.21	−0.21	−0.35
EPS (Rs)	−0.11	−0.10	−0.10	−0.14	−0.11	−0.11	−0.08	−0.16	−0.11	−0.13	−0.13	−0.20

MPS Pharmaa profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

MPS Pharmaa Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1.36	2.85	4.10	0.84	0.00	0.00	0.04	0.00	0.00	0.00	0.00	0.00
Expenses	1.83	9.70	4.61	1.55	0.66	4.13	0.70	0.94	0.79	0.76	0.94	0.90
Operating Profit	−0.50	−6.91	−0.54	−0.74	−0.68	−4.15	−0.69	−0.96	−0.81	−0.78	−0.96	−0.98
OPM %	−36.3%	−242.3%	−13.0%	−88.0%	—	—	−2,266.7%	—	—	—	—	—
Other Income	0.00	0.04	0.07	0.03	0.02	0.19	0.27	0.01	0.08	0.06	0.05	0.05
Interest	0.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.61	0.58	0.58	0.58	0.56	0.55	0.50	0.14	0.14	0.14	0.14	0.12
Profit before tax	−1.20	−7.45	−1.07	−1.29	−1.22	−4.49	−0.94	−1.07	−0.85	−0.86	−1.05	−1.08
Tax %	−0.8%	−0.8%	−17.9%	−3.8%	−5.7%	−1.8%	−84.9%	−1.8%	−2.3%	3.5%	−3.7%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.19	0.00	0.00	0.00	0.00	0.00	—
Net Profit	−1.18	−7.37	−0.86	−1.24	−1.16	−4.41	−0.13	−1.04	−0.82	−0.89	−1.01	−0.98
EPS (Rs)	−0.61	−3.86	−0.47	−0.66	−0.62	−2.32	−0.08	−0.56	−0.44	−0.48	−0.54	−0.57
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

MPS Pharmaa balance sheet

₹ crore, at each year end.

MPS Pharmaa Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	14.98	19.08	19.05	19.04	19.05	19.06	19.07	19.08	19.06	19.04	19.05	19.07
Reserves	4.16	−0.14	−7.51	−8.34	−9.57	−10.74	−15.14	−15.26	−16.30	−17.13	−18.01	−19.02
Borrowings	7.79	6.65	2.91	2.91	2.52	2.54	5.69	5.81	6.77	7.28	7.47	7.52
Other Liabilities	5.41	2.96	6.45	5.52	5.54	5.55	1.68	0.53	0.64	0.71	0.81	0.89
Total Liabilities	32.34	28.55	20.90	19.13	17.54	16.41	11.30	10.16	10.17	9.90	9.32	8.46
Fixed Assets	8.20	7.63	7.05	6.46	5.87	5.25	4.67	4.16	4.13	4.00	3.82	3.65
CWIP	6.14	6.14	5.50	5.20	5.42	5.01	3.89	3.41	3.39	3.25	2.90	2.40
Investments	0.93	0.93	0.91	0.93	0.91	0.93	0.55	0.55	0.53	0.53	0.55	0.55
Other Assets	17.07	13.85	7.44	6.54	5.34	5.22	2.19	2.04	2.12	2.12	2.05	1.86
Inventories	7.34	7.51	1.12	0.56	0.56	0.56	0.56	0.54	0.49	0.49	0.49	0.34
Trade receivables	7.70	4.28	4.15	3.87	2.62	2.54	0.60	0.04	0.04	0.03	0.02	0.00
Cash & equivalents	0.03	0.04	0.07	0.03	0.03	0.02	0.02	0.02	0.02	0.02	0.00	0.00
Total Assets	32.34	28.55	20.90	19.13	17.54	16.41	11.30	10.16	10.17	9.90	9.32	8.46

MPS Pharmaa cash flow

₹ crore, for each year.

MPS Pharmaa Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	2.17	1.26	0.38	−0.35	0.62	−0.50	−0.94	−4.35	−0.88	−0.64	−0.58	−0.60
Cash from investing activity	−0.45	−0.06	0.64	0.31	−0.23	0.47	1.55	0.47	−0.11	0.13	0.39	0.53
Cash from financing activity	−1.74	−1.18	−0.97	0.00	−0.38	0.02	−0.60	3.87	0.95	0.50	0.17	0.06
Net cash flow	−0.02	0.00	0.01	−0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Capex	0.43	0.00	0.00	0.00	0.21	0.00	0.00	0.00	0.11	0.01	0.00	0.49
Free cash flow	1.73	1.21	1.01	−0.05	0.40	−0.05	0.23	−3.89	−0.98	−0.52	−0.20	−0.08
CFO / OP %	267.0%	−292.0%	−5.0%	64.0%	−84.0%	73.0%	22.0%	638.0%	92.0%	79.0%	74.0%	62.0%

MPS Pharmaa ratios

Working-capital days and returns, by year.

MPS Pharmaa Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	230	1,155	533	345	1,149	—	—	366	—	—	—	—
Inventory days	273	6,543	49	58	253	—	—	4,014	4,562	—	—	—
Days payable	123	556	16	14	71	—	—	876	1,825	—	—	—
Cash conversion cycle	380	7,142	566	389	1,330	—	—	3,504	—	—	—	—
Working capital days	210	1,726	−115	−86	−848	—	—	−49,396	—	—	—	—
ROCE %	0.6%	−4.2%	−37.0%	−7.5%	−10.0%	−10.7%	−45.5%	−9.6%	−11.2%	−9.1%	−9.7%	−13.1%

MPS Pharmaa: frequently asked questions

What are the latest quarterly results of MPS Pharmaa?

For the Mar 2026 quarter, MPS Pharmaa reported sales of ₹0 Cr and net profit of −₹0.35 Cr.

What is the annual revenue of MPS Pharmaa?

MPS Pharmaa's sales for the year to Mar 2026 were ₹0 Cr; over the last twelve months they were ₹0 Cr.

What is the net profit of MPS Pharmaa?

Net profit for the year to Mar 2026 was −₹1.01 Cr, and −₹0.98 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.57.

How much debt does MPS Pharmaa have?

MPS Pharmaa reported borrowings of ₹7.52 Cr at Mar 2026, against cash and equivalents of ₹0 Cr.

What is the free cash flow of MPS Pharmaa?

Cash from operations was −₹0.60 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.08 Cr.

Loading…